Table 2.
Characteristics of human herpesviruses, Chlamydiae and parvovirus
| Organism | Receptors | Main cellular tropism | Proposed latency cell | Other tropism | References |
| EBV | CD21, MHC-II, α5β1 integrin | B | B | EPC, EC | [8] |
| CMV | EGFR | M/M | M/M; EC | N, EPC, EC | [174] |
| HHV6 | CD46+ | M/M, T, B | M/M | N, EPC | [175] |
| HHV7 | CD4+ heparan sulfate receptor | T | M/M | N, EPC, EC | [176,177] |
| HHV8 | Heparan sulfate receptor, EGFR | EC, M/M, B, T | B | N, EPC | [174,178] |
| Chlamydia pneumoniae | Heparan sulfate receptor | M/M | EC, EPC | [179] | |
| Chlamydia trachomatis | M/M | EC, EPC | |||
| Parvovirus B19 | Erythrocyte P antigen | Erythroid precursors | EC | [66,67] |
B, B cells; CMV, cytomegalovirus; EBV, Epstein–Barr virus; EC, endothelial cells; EGFR, epidermal growth factor receptor; EPC, epithelial cells; HHV, human herpesvirus; MHC, major histocompatibility complex; M/M, myelomonocytic cells; N, neural cells; T, T cells.